Abstract:Background: Diabetes mellitus is one of the common metabolic disorders that have high morbidity. Diabetic patients are prone to developing chronic nonhealing foot ulcers, a leading cause of limb amputations. Autologous platelet-rich plasma (PRP) contains proteins rich in multiple growth factors (GFs) used in treating chronic diabetic foot ulcers and helps in early tissue repair and regeneration. This study aimed to evaluate the safety and enhanced efficacy of autologous PRP, in the healing rate of chronic diabetic foot ulcers. Methodology: This was a randomized control open clinical study of 18-month duration involving 50 patients in each group. Patients admitted with type 2 diabetes mellitus–with hemoglobin A1c >6.5 and chronic healing long-standing ulcer of >1-month duration were included. Patients with severe anemia and cardiac illness, osteomyelitis were excluded as they are independent risk factors that affect ulcer healing. Admitted patients were randomly allocated to receive either PRP or normal saline dressings using computer-generated random numbers. Simple debridement was done to remove necrotic tissue on the day of admission before the first application of PRP or normal saline dressing. PRP was prepared after centrifugation of autologous whole blood (10 ml). In the study group, prepared and stored PRP (1–2 ml) was applied topically in drops using a syringe to cover the floor of the ulcer and covered with a sterile transparent dressing. In the control group, normal saline was soaked in the gauze and kept over the surface of the ulcer covered with a transparent dressing. The patient will receive dressings with PRP or saline according to the group they were placed in. Progress was monitored, and the dressing was changed every 3 rd day for up to 21 days. The wound area measurement was done by measuring the surface area of the wound with the help of a transparent sheet and graph. A transparent sheet was placed on the ulcer, and the total area of the ulcer was marked and recorded. The marked transparent sheet was placed over a graph sheet, and the outline was plotted. The area was calculated and recorded in cm 2 . The growth and healing of the wound are considered when a part of the wound shows an increase in granulation and a decrease in slough. Periodic photographs were taken on day 3, day 7, day 14, and day 21 and assessed. Two groups were compared for wound size reduction and duration of healing. The collected data were entered in Excel 2010 and measured using mean and standard deviation for continuous variables and in percentage for dichotomous and categorical variables. Two groups were compared using an independent t -test for continuous variables and a Chi-square test for dichotomous and categorical variables. Results: In our study on 100 patients, 50 in each group with ulcers of Wagner's Grade 1 and Grade 2, the appearance of granulation and size reduction rate is delayed with normal saline dressing (44/50 patients [88%]). In the autologous PRP dressing group, the rate of granulation from the 7 th day of dressing was greater (50/50, patients [100%]) and ulcer size reduction is statistically significant (Chi-square value 6.38, P < 0.001) when compared to normal saline. Conclusions: Autologous PRP used in chronic diabetic foot ulcer dressing enhances healing and shows a significant reduction in wound size over a shorter duration when compared with saline dressing. Autologous PRP is safe, efficient, and simple to prepare, providing necessary GFs to improve healing without adverse events.

Efficacy and Safety of Platelet-Rich Plasma for Patients with Diabetic Ulcers: A Systematic Review and Meta-analysis.

Efficacy of Topical Recombinant Human Platelet-Derived Growth Factor for Treatment of Diabetic Lower-Extremity Ulcers: Systematic Review and Meta-Analysis

Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis

Efficacy and Safety of Platelet-Rich Plasma for Pressure Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review

Effect of platelet‐rich plasma on healing of lower extremity diabetic skin ulcers: A meta‐analysis

Efficacy and safety of platelet‐rich plasma in the treatment of venous ulcers: A systematic review and meta‐analysis of randomized controlled trials

Efficacy and Safety of Allogeneic Platelet Rich Plasma in Treatment of Diabetic Patients with Lower Limb Ulcers: A Pilot Study

Autologous platelet-rich plasma treatment for patients with diabetic foot ulcers: a meta-analysis of randomized studies

Efficacy of autologous platelet‐rich plasma combined with negative pressure sealing drainage in the treatment of patients with diabetic foot ulcer

Comparison of Allogeneic Platelet-rich Plasma With Autologous Platelet-rich Plasma for the Treatment of Diabetic Lower Extremity Ulcers

Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers

Safety and efficacy of platelet rich plasma in the management of diabetic foot ulcer

Clinical Study of Platelet-Rich Plasma (PRP) for Lower Extremity Venous Ulcers: A Meta-Analysis and Systematic Review

Effectiveness of autologous platelet-rich plasma dressing in healing chronic diabetic foot ulcers in comparison with saline dressing. A randomized control study

Effect of platelet‐rich plasma vs standard management for the treatment of diabetic foot ulcer wounds: A meta‐analysis

Autologous Platelet-Rich Gel Treatment For Diabetic Chronic Cutaneous Ulcers: A Meta-Analysis Of Randomized Controlled Trials

Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcer

Platelet-rich Plasma (PRP) in the Treatment of Diabetic Foot Ulcers and Its Regulation of Autophagy.

Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer

Efficacy and safety of allogeneic platelet-rich plasma in chronic wound treatment: a meta-analysis of randomized controlled trials